CA1307740C - Preparation pharmaceutique et methode permettant d'inhiber la replication du htlv-iii (sida) - Google Patents

Preparation pharmaceutique et methode permettant d'inhiber la replication du htlv-iii (sida)

Info

Publication number
CA1307740C
CA1307740C CA000543641A CA543641A CA1307740C CA 1307740 C CA1307740 C CA 1307740C CA 000543641 A CA000543641 A CA 000543641A CA 543641 A CA543641 A CA 543641A CA 1307740 C CA1307740 C CA 1307740C
Authority
CA
Canada
Prior art keywords
dextran sulphate
htlv
iii
pharmaceutical preparation
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000543641A
Other languages
English (en)
Inventor
Thomas C. Usher
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA000543641A priority Critical patent/CA1307740C/fr
Application granted granted Critical
Publication of CA1307740C publication Critical patent/CA1307740C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000543641A 1987-08-05 1987-08-05 Preparation pharmaceutique et methode permettant d'inhiber la replication du htlv-iii (sida) Expired - Lifetime CA1307740C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000543641A CA1307740C (fr) 1987-08-05 1987-08-05 Preparation pharmaceutique et methode permettant d'inhiber la replication du htlv-iii (sida)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA000543641A CA1307740C (fr) 1987-08-05 1987-08-05 Preparation pharmaceutique et methode permettant d'inhiber la replication du htlv-iii (sida)

Publications (1)

Publication Number Publication Date
CA1307740C true CA1307740C (fr) 1992-09-22

Family

ID=4136200

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000543641A Expired - Lifetime CA1307740C (fr) 1987-08-05 1987-08-05 Preparation pharmaceutique et methode permettant d'inhiber la replication du htlv-iii (sida)

Country Status (1)

Country Link
CA (1) CA1307740C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006003521A1 (fr) * 2004-02-06 2006-01-12 Monash University Utilisation a haute dose et sur un intervalle court de polysaccharides sulfates dans le traitement des infections

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006003521A1 (fr) * 2004-02-06 2006-01-12 Monash University Utilisation a haute dose et sur un intervalle court de polysaccharides sulfates dans le traitement des infections

Similar Documents

Publication Publication Date Title
DE69023748T2 (de) Verwendung von Stickstoff enthaltenden Makrozyklen zur Behandlung retroviraler Infektionen.
KR100638684B1 (ko) 말초 혈관 질환의 치료를 위한 9-데옥시-2',9-알파-메타노-3-옥사-4,5,6-트리노르-3,7-(1',3'-인터페닐렌)-13,14-디하이드로-프로스타글란딘 에프1의 용도
US6001826A (en) Chemical compounds
US5565448A (en) Medicament
Grewal Pharmacology of 8-aminoquinolines
MD1688G2 (ro) Benzotiofen, benzofuran şi indoltiazepinone, oxazepinone şi diazepinone, compoziţie farmaceutică, metodă de inhibare a aderării leucocitelor la celulele endoteliale pentru tratamentul proceselor inflamatorii şi metodă de tratament al mamiferelor infectate cu HIV infecţie .
TNSN90021A1 (fr) Procede de preparation de tetrahydroimidazo (1,4) benzodiazepin -2- thiones antivirales
JPH072663A (ja) ウィルス感染治療剤
US5616577A (en) Protein Kinase C inhibitor
CA1307740C (fr) Preparation pharmaceutique et methode permettant d'inhiber la replication du htlv-iii (sida)
US4978687A (en) Anti-viral agent
US4892876A (en) Method for inhibiting HIV and an pharmaceutical composition therefor
CA2193396A1 (fr) Composition pharmaceutique pour prevenir et/ou traiter des infections virales, ainsi qu'eventuellement des inflammations, et utilisation de cette composition
Scott et al. Further study of some 1-substituted theobromine compounds
WO1994003169A1 (fr) Melange d'un intercepteur de radicaux libres et d'un chelateur du fer utilise dans le traitement de la depranocytose
EP0476391B1 (fr) Composition anti-SIDA contenant cépharanthine comme agent thérapeutique
NZ205587A (en) Composition comprising undecylenic acid for treating herpes simplex i
KR100227095B1 (ko) 항 hiv제
CA1306694C (fr) Preparation pharmaceutique et methode d'inhibition de la replication du virus htlv-iii (sida)
Ishii et al. In vivo efficacy of levamisole against larval stages of Angiostrongylus cantonensis and A. costaricensis
DK167148B1 (da) Komplekser af selen- og tellur-ethylendioxy-derivater, farmaceutiske praeparater deraf og anvendelse af komplekserne til fremstilling af farmaceutiske praeparater
KR0124028B1 (ko) 후천성 면역 결핍증의 예방 및 치료제
PT97609A (pt) Processo para a preparacao de uma composicao farmaceutica para o tratamento de celulas infectadas com o virus da imunodeficiencia humana e dispositivo ou artigo tratado com essa composicao
US5264621A (en) Anti-virus agent
KR0131323B1 (ko) Bu-3608을 함유한 인체면역결핍 바이러스에 대한 항바이러스 조성물

Legal Events

Date Code Title Description
MKEX Expiry